Literature DB >> 35995971

Acute administration of ketone beta-hydroxybutyrate downregulates 7T proton magnetic resonance spectroscopy-derived levels of anterior and posterior cingulate GABA and glutamate in healthy adults.

Antoine Hone-Blanchet1, Botond Antal1,2, Liam McMahon2, Andrew Lithen2, Nathan A Smith3,4, Steven Stufflebeam1, Yi-Fen Yen1, Alexander Lin1, Bruce G Jenkins1, Lilianne R Mujica-Parodi1,2,5,6, Eva-Maria Ratai7.   

Abstract

Glucose metabolism is impaired in brain aging and several neurological conditions. Beneficial effects of ketones have been reported in the context of protecting the aging brain, however, their neurophysiological effect is still largely uncharacterized, hurdling their development as a valid therapeutic option. In this report, we investigate the neurochemical effect of the acute administration of a ketone d-beta-hydroxybutyrate (D-βHB) monoester in fasting healthy participants with ultrahigh-field proton magnetic resonance spectroscopy (MRS). In two within-subject metabolic intervention experiments, 7 T MRS data were obtained in fasting healthy participants (1) in the anterior cingulate cortex pre- and post-administration of D-βHB (N = 16), and (2) in the posterior cingulate cortex pre- and post-administration of D-βHB compared to active control glucose (N = 26). Effect of age and blood levels of D-βHB and glucose were used to further explore the effect of D-βHB and glucose on MRS metabolites. Results show that levels of GABA and Glu were significantly reduced in the anterior and posterior cortices after administration of D-βHB. Importantly, the effect was specific to D-βHB and not observed after administration of glucose. The magnitude of the effect on GABA and Glu was significantly predicted by older age and by elevation of blood levels of D-βHB. Together, our results show that administration of ketones acutely impacts main inhibitory and excitatory transmitters in the whole fasting cortex, compared to normal energy substrate glucose. Critically, such effects have an increased magnitude in older age, suggesting an increased sensitivity to ketones with brain aging.
© 2022. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Year:  2022        PMID: 35995971     DOI: 10.1038/s41386-022-01364-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  52 in total

Review 1.  An energy budget for signaling in the grey matter of the brain.

Authors:  D Attwell; S B Laughlin
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

Review 2.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.

Authors:  Dimitrios Kapogiannis; Mark P Mattson
Journal:  Lancet Neurol       Date:  2010-12-10       Impact factor: 44.182

3.  Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging.

Authors:  Grégoria Kalpouzos; Gaël Chételat; Jean-Claude Baron; Brigitte Landeau; Katell Mevel; Christine Godeau; Louisa Barré; Jean-Marc Constans; Fausto Viader; Francis Eustache; Béatrice Desgranges
Journal:  Neurobiol Aging       Date:  2007-07-13       Impact factor: 4.673

4.  Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer's disease.

Authors:  Miranka Wirth; Alexandre Bejanin; Renaud La Joie; Eider M Arenaza-Urquijo; Julie Gonneaud; Brigitte Landeau; Audrey Perrotin; Florence Mézenge; Vincent de La Sayette; Béatrice Desgranges; Gaël Chételat
Journal:  Neurobiol Aging       Date:  2017-11-07       Impact factor: 4.673

5.  Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

Authors:  M Higuchi; M Tashiro; H Arai; N Okamura; S Hara; S Higuchi; M Itoh; R W Shin; J Q Trojanowski; H Sasaki
Journal:  Exp Neurol       Date:  2000-04       Impact factor: 5.330

6.  Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Authors:  Andrea Ciarmiello; Milena Cannella; Secondo Lastoria; Maria Simonelli; Luigi Frati; David C Rubinsztein; Ferdinando Squitieri
Journal:  J Nucl Med       Date:  2006-02       Impact factor: 10.057

Review 7.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Sugar for the brain: the role of glucose in physiological and pathological brain function.

Authors:  Philipp Mergenthaler; Ute Lindauer; Gerald A Dienel; Andreas Meisel
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

9.  Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain.

Authors:  Roger Mullins; David Reiter; Dimitrios Kapogiannis
Journal:  Ann Clin Transl Neurol       Date:  2018-01-29       Impact factor: 4.511

10.  Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.

Authors:  Janina Krell-Roesch; Jeremy A Syrjanen; Maria Vassilaki; Val J Lowe; Prashanthi Vemuri; Michelle M Mielke; Mary M Machulda; Gorazd B Stokin; Teresa J Christianson; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Yonas E Geda
Journal:  Am J Geriatr Psychiatry       Date:  2020-06-17       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.